Sprache: Englisch
Verlag: New York/ NY, Springer US., 2006
ISBN 10: 0387310460 ISBN 13: 9780387310466
Anbieter: Universitätsbuchhandlung Herta Hold GmbH, Berlin, Deutschland
16 x 24 cm. XX, 538 S. XX, 538 p. Hardcover. Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. Sprache: Englisch.
Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
EUR 100,45
Anzahl: 1 verfügbar
In den WarenkorbZustand: Used. pp. 564 52:B&W 6.14 x 9.21in or 234 x 156mm (Royal 8vo) Case Laminate on White w/Gloss Lam.
Zustand: Used. pp. 564.
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 115,35
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
EUR 127,84
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. First overview of up-to-date antiviral strategiesReview of drug design and developmentPresents novel Ideas and concepts to develop alternative antiviral drugsWritten by leading scientist in the fieldAntiviral drugs are vit.
Buch. Zustand: Neu. Neuware - Antiviral drugs are important tools for treatment or prevention of viral infections. These drugs were first used for monotherapy, but nowadays combinations of antiviral agents are often part of a standard treatment as evidenced by e.g. HAART (highly active antiretroviral therapy). However, in almost every case of antiviral therapy, drug resistant viruses appear. In addition, the low oral bioavailability, toxicity and the number of severe side effects still pose significant problems. All of the latter issues limit the clinical usefulness and drive the need for improved antiviral strategies. These strategies include new drugs and targets, novel modes of action, vector-based treatments and even the block of defined genes by inhibiting mRNA formation (siRNA). Highlights of this book include the discussion of:- novel, promising compounds- concepts of therapy for new/emerging viruses- managing drug resistance- new therapeutic strategiesThis book presents an overview of the most recent developments. Contributions were carefully selected to ensure quality coverage by acknowledged experts over a wide spectrum and should prove to be of great value to students and serve as a compendium for R and D and educational professionals.